Barnes & Noble Shares Soar After Investor Discusses Sale with Founder
07 Sep, 2018
Shares of Cara Therapeutic Inc. (NASDAQ: CARA) fell 31 percent on Friday after the company announced disappointing results on the CR845 oral medication from a phase 2b trial.Cara is a biopharmaceutical company that focuses on developing medications ..
Alphabet Inc. (NASDAQ: GOOGL) is on the defensive. Just one day after the European union hit Google with a $2.7 billion antitrust fine, a Canadian court has ruled against the tech giant as well. A court in British Columbia ruled that Google must rem..
European Union antitrust officials fined Alphabet Inc. (NASDAQ: GOOGL) unit Google with a record 2.42-billion-euro, equivalent to $2.7 billion. The EU is demonstrating a tough position against the tech and internet giant, claiming that Google h..
The U.S. tequila brand, Casamigos, which was co-founded by George Clooney, will be sold to Diageo Plc (NYSE: DEO) for $1 billion dollars.Clooney and his partners, Rande Gerber and Michael Meldman, founded the company on a whim. In a Business Insider..
Clovis Oncology Inc. (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. The company’s shares jumped ab..
Adamis Pharmaceuticals Corp. (NASDAQ: ADMP) shares jumped more than 60% on Thursday, after the U.S Food and Drug Administration (FDA) approved the Adamis’ Epinephrine injection, a generic version of a Mylan N.V.’s EpiPen, which is a..
The cryptocurrency market is growing rapidly in the recent years. The overall market capitalization has already passed $100 billion to $113 billion. Bitcoin, one of the most popular digital currency, surged to above $3,000 for the first time on..
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).